Ascendis Pharma A/S (NASDAQ:ASND) Q4 2022 Earnings Call Transcript February 16, 2023
Operator: Good day, and thank you for standing by. Welcome to the Ascendis Pharma Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session . Please be advised that, today’s conference is being recorded. I would now like to turn the call over to now your speaker for today, Tim Lee,...
